Onbrez Breezhaler

Onbrez Breezhaler

indacaterol

Manufacturer:

Novartis Indonesia
Concise Prescribing Info
Contents
Indacaterol maleate
Indications/Uses
Maintenance bronchodilator treatment of airflow obstruction in adult patients w/ COPD.
Dosage/Direction for Use
Adult Recommended dose: 150 mcg once-daily inhalation at the same time daily. May be increased on medical advice. Max: 300 mcg once daily.
Contraindications
Hypersensitivity to lactose. Treatment of acute episodes of bronchospasm.
Special Precautions
Asthma; discontinue treatment if paradoxical bronchospasm occurs. CV disorders eg, CAD, acute MI, cardiac arrhythmias, HTN, convulsive disorders or thyrotoxicosis; patients unusually responsive to β2-adrenergics; hypokalaemia, hypoxia, concomitant treatment w/ other long-acting β2-adrenergic agonists. Monitor plasma glucose in diabetic patients. Patient under labour/delivery. Pregnancy & lactation. Childn <18 yr.
Adverse Reactions
Nasopharyngitis, upper resp tract infection, sinusitis; cough, oropharyngeal pain, rhinorrhea; muscle spasm, myalgia, musculoskeletal pain; peripheral oedema, chest pain; ischaemic heart disease; DM & hyperglycaemia; dry mouth.
Drug Interactions
MAOIs, TCAs, drugs known to prolong QT-interval; sympathomimetic agents; methylxanthine derivatives, steroids or non-K-sparing diuretics; β-adrenergic blockers (including eye drops); ketoconazole, erythromycin, verapamil.
ATC Classification
R03AC18 - indacaterol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Onbrez Breezhaler inhalation powd cap 150 mcg
Packing/Price
10's (Rp199,187/pak);30's (Rp553,397/pak)
Form
Onbrez Breezhaler inhalation powd cap 300 mcg
Packing/Price
10's (Rp199,187/pak);30's (Rp553,397/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in